COURT-RULING ·Filed May 1, 2026

ZBH

Zimmer Biomet
NEUTRAL
Impact 3/10
Horizonmonths Processed5mo ago CourtView Ruling on CourtListener
Court ruling (appellate)
Actionable Insight • Neutral

The case continues on a narrow fraud claim, but the financial exposure is small relative to market cap. Monitor for next hearings or settlement discussions; no immediate trading catalyst.

DirectionNeutral
Confidencehigh
Horizonmonths
Final — all horizons settled through T+60d
ZBH ▲ +11.12% at T+60d
NEUTRAL call ✓ call won +11.12% · α vs SPY +8.56% · entry $82.86 → $92.07
Entry anchored
Apr 30, 03:59 PM ET
via exchange tick
T+1d
-0.29%
call -0.29% · α +0.05%
$82.62
settled 5mo ago
T+5d
+0.62%
call +0.62% · α -1.73%
$83.37
settled 5mo ago
T+20d
+0.10%
call +0.10% · α -5.18%
$82.94
settled 4mo ago
T+60d
+11.12%
call +11.12% · α +8.56%
$92.07
settled 2mo ago

Price Chart

Loading chart...

Executive Summary

Delaware Chancery Court partially granted Zimmer Biomet's motion to dismiss in an earnout dispute from its acquisition of Embody. Fraud claim allowed to proceed only on alleged misrepresentation about budget approval for sales representatives; breach of contract and implied covenant claims dismissed.

Court Ruling Details

Ruling Date
May 1, 2026
Court
Court of Chancery of Delaware
Court Level
District
Judge
David, V.C.
Case Type
contract
Ruling Type
motion to dismiss
Outcome
PARTIAL — mixed ruling, some claims won/lost
Damages Range
$47.5 million
Will It Be Appealed?
N/A (final)
Precedent Risk
LOW
Market Cap Exposure
0.3%

Key Facts

  • Acquisition of Embody for $155M upfront plus up to $120M in earnouts; only $72.5M paid.
  • Court dismissed breach of contract and implied covenant claims.
  • Only one narrow fraud claim survives: representation that Zimmer had budget approval to hire 94 sales representatives.
  • Potential damages limited to earnout shortfall (~$47.5M), immaterial relative to $16B market cap.

Financial Impact

Potential damages of approximately $47.5 million (earnout shortfall) but not yet awarded; limited to <0.3% of market cap.

Risk Factors

  • Litigation costs and management distraction
  • Possible adverse verdict on surviving fraud claim, though exposure is limited

Market Snapshot

Exchange
NYSE
Sector
Orthopedic, Prosthetic & Surgical Appliances & Supplies
Analyst Consensus
32% bullish (34 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 1 court opinion from CourtListener.

DocumentAccession Number
COURT-RULING Data (Synthetic)court-30mdw9rv-ZBH
9 reports for ZBH
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for ZBH — sortable, filterable
TypeNow
Sep 15, 2026
17d ago
Insider Cluster
NEUTRAL ★ 3/10
$98.41 $93.98▼ −4.50%▼ −6.63%$87.79 (−10.79%)
Sep 2, 2026
4w ago
Court Ruling
NEUTRAL ★ 2/10
$99.50 $92.44▼ −7.10%▼ −6.14%$87.79 (−11.77%)
Aug 17, 2026
6w ago
Court Ruling
NEUTRAL ★ 2/10
$98.20 $100.98▲ +2.83%▲ +4.02%$87.79 (−10.60%)
Aug 5, 2026
8w ago
8-K
BULLISH ★ 6/10
$98.16 $97.89▼ −0.28%▼ −0.63%$87.79 (−10.56%)
May 12, 2026
20w ago
8-K
NEUTRAL ★ 4/10
$83.34 $85.14▲ +2.16%▲ +2.09%$87.79 (+5.34%)
May 1, 2026
22w ago
Court Ruling
NEUTRAL ★ 3/10
$82.86 $83.37▲ +0.62%▼ −1.73%$87.79 (+5.95%)
Apr 28, 2026
22w ago
8-K
NEUTRAL ★ 3/10
$82.45 $82.63▲ +0.22%▼ −1.47%$87.79 (+6.48%)
Apr 28, 2026
22w ago
8-K
BULLISH ★ 8/10
$82.45 $82.63▲ +0.22%▼ −1.47%$87.79 (+6.48%)
Apr 1, 2026
26w ago
DEFA14A
NEUTRAL ★ 3/10
$91.00 $93.03▲ +2.24%▼ −1.53%$87.79 (−3.52%)
Showing 9 of 9

US Market Status

Market Open — Closes in 45m

Subscribe to SecBot

Get Real-Time Court Ruling Intelligence

Market-moving court rulings analyzed within minutes. Patent verdicts, antitrust decisions, class certifications, and more — parsed and scored by AI.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access